Page 1328 - Hall et al (2015) Principles of Critical Care-McGraw-Hill
P. 1328

References     3


                      61. Klimo P Jr., Thompson CJ, Kestle JR, Schmidt MH. A     78. Vecht CJ, Haaxma-Reiche H, van Putten WL, de Visser M,
                          meta-analysis of surgery versus conventional radiotherapy for   Vries EP, Twijnstra A. Initial bolus of conventional versus high-
                        the treatment of metastatic spinal epidural disease. Neuro Oncol.   dose dexamethasone in metastatic spinal cord compression.
                        January 2005;7(1):64-76.                                Neurology. September 1989;39(9):1255-1257.
                      62. Eleraky M, Papanastassiou I, Vrionis FD. Management of meta-    79. Sciubba DM, Gokaslan ZL. Diagnosis and management of
                        static spine disease. Curr Opin Support Palliat Care. September   metastatic spine disease. Surg Oncol. November 2006;15(3):
                        2010;4(3):182-188.                                      141-151.
                      63. Kienstra GE, Terwee CB, Dekker FW, et al. Prediction of spinal     80. Navi BB, Reichman JS, Berlin D, et al. Intracerebral and subarach-
                        epidural metastases. Arch Neurol. May 2000;57(5):690-695.  noid hemorrhage in patients with cancer. Neurology. February 9,
                      64. Sun H, Nemecek AN. Optimal management of malignant    2010;74(6):494-501.
                          epidural spinal cord compression.  Hematol Oncol Clin North     81. Quinn JA, DeAngelis LM. Neurologic emergencies in the cancer
                        Am. June 2010;24(3):537-551.                            patient. Semin Oncol. June 2000;27(3):311-321.
                      65. McCurdy MT, Shanholtz CB. Oncologic emergencies. Crit Care     82. Rogers  LR.  Cerebrovascular  complications  in  patients  with
                        Med. July 2012;40(7):2212-2222.                           cancer. Semin Neurol. December 2004;24(4):453-460.
                      66. Hamamoto Y, Kataoka M, Senba T, et al. Vertebral metastases     83. Najima Y, Ohashi K, Miyazawa M, et al. Intracranial hemorrhage
                        with high risk of symptomatic malignant spinal cord compres-  following  allogeneic  hematopoietic  stem  cell  transplantation.
                        sion. Jpn J Clin Oncol. July 2009;39(7):431-434.        Am J Hematol. May 2009;84(5):298-301.
                      67. Rodichok LD, Ruckdeschel JC, Harper GR, et al. Early detection     84. Gonzalez-Duarte A, Garcia-Ramos  GS, Valdes-Ferrer SI,
                        and treatment of spinal epidural metastases: the role of myelog-  Cantu-Brito C. Clinical description of intracranial hemorrhage
                        raphy. Ann Neurol. December 1986;20(6):696-702.         associated with bleeding disorders.  J Stroke Cerebrovasc Dis.
                      68. Helweg-Larsen S, Sorensen PS. Symptoms and signs in meta-  July-August 2008;17(4):204-207.
                        static spinal cord compression: a study of progression from     85. Chang MC, Chen TY, Tang JL, et al. Leukapheresis and cranial
                        first symptom until diagnosis in 153 patients.  Eur J Cancer.   irradiation in patients with hyperleukocytic acute myeloid
                        1994;30A(3):396-398.                                    leukemia: no impact on early mortality and intracranial hemor-
                      69. Ruckdeschel JC. Rapid, cost-effective diagnosis of spinal cord   rhage. Am J Hematol. November 2007;82(11):976-980.
                        compression due to cancer.  Cancer Control. July 1995;2(4):     86. Ruggiero A, Attina G, Piastra M, et al. Severe hyperleukocytosis
                        320-323.                                                and multifocal intracranial haemorrhage: not always a fatal
                      70. Enkaoua EA, Doursounian L, Chatellier G, Mabesoone F,     outcome. Int J Hematol. July 2009;90(1):87-90.
                        Aimard T, Saillant G. Vertebral metastases: a critical apprecia-    87. Chen CY, Tai CH, Tsay W,  Chen PY,  Tien HF.  Prediction of
                        tion of the preoperative prognostic tokuhashi score in a series   fatal intracranial hemorrhage in patients with acute myeloid
                        of  71 cases.  Spine (Phila Pa 1976).  October 1,  1997;22(19):   leukemia. Ann Oncol. June 2009;20(6):1100-1104.
                        2293-2298.                                           88. Rogers LR. Cerebrovascular complications in cancer patients.
                      71. Tokuhashi  Y, Matsuzaki H,  Oda H,  Oshima  M, Ryu  J. A   Neurol Clin. February 2003;21(1):167-192.
                        revised scoring system for preoperative evaluation of meta-    89. Wijman  CA,  Venkatasubramanian  C,  Bruins  S,  Fischbein
                        static spine tumor prognosis. Spine (Phila Pa 1976). October 1,   N, Schwartz N. Utility of early MRI in the diagnosis and
                        2005;30(19):2186-2191.                                  management of acute spontaneous intracerebral hemorrhage.
                      72. Tomita K, Kawahara N, Kobayashi T, Yoshida A, Murakami H,   Cerebrovasc Dis. 2010;30(5):456-463.
                        Akamaru T. Surgical strategy for spinal metastases. Spine (Phila     90. Nyquist P. Management of acute intracranial and intraventricu-
                        Pa 1976). February 1, 2001;26(3):298-306.               lar hemorrhage. Crit Care Med. March 2010;38(3):946-953.
                      73. van der Linden YM, Dijkstra SP, Vonk EJ, Marijnen CA, Leer     91. Tallman MS, Andersen JW, Schiffer CA, et al. All-trans-retinoic
                        JW. Prediction of survival in patients with metastases in the spi-  acid in acute promyelocytic leukemia. N Engl J Med. October 9,
                        nal column: results based on a randomized trial of radiotherapy.   1997;337(15):1021-1028.
                        Cancer. January 15, 2005;103(2):320-328.
                      74. Harrington KD.  Orthopedic  surgical  management of  skel-    92. Body JJ. Hypercalcemia of malignancy. Semin Nephrol. January
                                                                                2004;24(1):48-54.
                        etal complications of malignancy. Cancer. October 15, 1997;80
                        (8 suppl):1614-1627.                                 93. Stewart AF. Clinical practice. Hypercalcemia associated with
                      75. Loblaw DA, Mitera G, Ford M, Laperriere NJ. A 2011 Updated   cancer. N Engl J Med. January 27, 2005;352(4):373-379.
                        systematic review and clinical practice guideline for the man-    94. Sargent JT, Smith OP. Haematological emergencies managing
                        agement of malignant extradural spinal cord compression. Int     hypercalcaemia  in adults and children with haematological
                        J Radiat Oncol Biol Phys. October 1, 2012;84(2):312-317.  disorders. Br J Haematol. May 2010;149(4):465-477.
                      76. Patchell RA, Tibbs PA, Regine WF, et al. Direct decompressive     95. Seymour JF, Gagel RF. Calcitriol: the major humoral mediator
                        surgical resection in the treatment of spinal cord compression   of hypercalcemia in Hodgkin’s disease and non-Hodgkin’s lym-
                        caused by metastatic cancer: a randomised trial. Lancet. August   phomas. Blood. September 1, 1993;82(5):1383-1394.
                        20-26, 2005;366(9486):643-648.                       96. Deftos LJ. Hypercalcemia in malignant and  inflammatory
                      77. Sorensen S, Helweg-Larsen S, Mouridsen H, Hansen HH. Effect     diseases.  Endocrinol Metab Clin North Am. March 2002;
                        of high-dose dexamethasone in carcinomatous metastatic spinal   31(1):141-158.
                        cord compression treated with radiotherapy: a randomised trial.     97. Ralston SH, Gallacher SJ, Patel U, Campbell J, Boyle IT. Cancer-
                        Eur J Cancer. 1994;30A(1):22-27.                        associated hypercalcemia: morbidity and mortality.  Clinical










            Section07-O-ref.indd   3                                                                                   1/21/2015   11:26:50 AM
   1323   1324   1325   1326   1327   1328   1329   1330   1331   1332   1333